S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 844 JPY 2.06% Market Closed
Market Cap: 76.4B JPY

Sosei Group Corp
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sosei Group Corp
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
S
Sosei Group Corp
TSE:4565
EPS (Diluted)
-ÂĄ67
CAGR 3-Years
-145%
CAGR 5-Years
-27%
CAGR 10-Years
-20%
Takeda Pharmaceutical Co Ltd
TSE:4502
EPS (Diluted)
ÂĄ20
CAGR 3-Years
-46%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
EPS (Diluted)
ÂĄ151
CAGR 3-Years
67%
CAGR 5-Years
20%
CAGR 10-Years
-11%
Otsuka Holdings Co Ltd
TSE:4578
EPS (Diluted)
ÂĄ850
CAGR 3-Years
61%
CAGR 5-Years
26%
CAGR 10-Years
12%
Chugai Pharmaceutical Co Ltd
TSE:4519
EPS (Diluted)
ÂĄ241
CAGR 3-Years
-12%
CAGR 5-Years
14%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
EPS (Diluted)
ÂĄ69
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
No Stocks Found

Sosei Group Corp
Glance View

Market Cap
76.4B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Intrinsic Value
1 189.81 JPY
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Sosei Group Corp's EPS (Diluted)?
EPS (Diluted)
-67.9 JPY

Based on the financial report for Sep 30, 2025, Sosei Group Corp's EPS (Diluted) amounts to -67.9 JPY.

What is Sosei Group Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-20%

Over the last year, the EPS (Diluted) growth was -64%. The average annual EPS (Diluted) growth rates for Sosei Group Corp have been -145% over the past three years , -27% over the past five years , and -20% over the past ten years .

Back to Top